Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 3
2019 pubmed 49 citations

Peptide-Loaded Cubosomes Functioning as an Antimicrobial Unit against Escherichia coli.

Boge. Lukas L; Browning. Kathryn L KL; Nordström. Randi R; Campana. Mario M; Damgaard. Liv S E LSE; Seth Caous. Josefin J; Hellsing. Maja M; Ringstad. Lovisa L; Andersson. Martin M

Key Findings

  • LL-37 can be successfully loaded into cubosome nanocarriers.
  • LL-37‑loaded cubosomes attach to bacterial‑mimicking membranes and cause distortion.
  • Direct imaging confirmed that the cubosome‑peptide complexes disrupt real E. coli cells.

Practical Outcomes

  • For DIY biohackers, this suggests that pairing LL-37 with a lipid‑based nanocarrier could boost its antibacterial power, especially for topical or gut‑related applications. However, the study is still at a laboratory stage—no dosage guidelines or ready‑to‑use formulations are provided, so further experimentation would be needed to translate this into a safe, effective protocol.

Summary

Scientists packed the natural antimicrobial peptide LL-37 into tiny, sponge‑like particles called cubosomes and showed that these combos stick to and damage E. coli bacterial membranes, killing the bugs more effectively than the peptide alone.

Abstract

Dispersions of cubic liquid crystalline phases, also known as cubosomes, have shown great promise as delivery vehicles for a wide range of medicines. Due to their ordered structure, comprising alternating hydrophilic and hydrophobic domains, cubosomes possess unique delivery properties and compatibility with both water-soluble and -insoluble drugs. However, the drug delivery mechanism and cubosome interaction with human cells and bacteria are still poorly understood. Herein, we reveal how cubosomes loaded with the human cathelicidin antimicrobial peptide LL-37, a system with high bacteria-killing effect, interact with the bacterial membrane and provide new insights into the eradication mechanism. Combining the advanced experimental techniques neutron reflectivity and quartz crystal microbalance with dissipation monitoring, a mechanistic drug delivery model for LL-37-loaded cubosomes on bacterial mimicking bilayers was constructed. Moreover, the cubosome interaction with Escherichia coli was directly visualized using super-resolution laser scanning microscopy and cryogenic electron tomography. We could conclude that cubosomes loaded with LL-37 adsorbed and distorted bacterial membranes, providing evidence that the peptide-loaded cubosomes function as an antimicrobial unit.

Study Information

Provider

pubmed

Year

2019

Date

2019-06-04T00:00:00.000Z

DOI

10.1021/acsami.9b01826

Citations

49

References

46